WATCHDOG WILL STUDY GENERIC DRUG PRICING

The federal Competition Bureau will study Canada's generic pharmaceutical industry this year to assess whether Canadians are reaping enough benefits from cheaper copy-cat drugs. Toronto Star (http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Article_Type1&c=Article&cid=1159566611195&call_pageid=968350072197&col=969048863851)